secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0000950170-23-047951
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals appoints James Robinson to board effective Oct 1, 2023
-----------------------------------------------------------------------------

- Robinson will serve as chair of the Compensation Committee and member of Audit Committee.
- Annual cash retainers of $42k for board service, $15.75k as comp chair, $10.5k for audit committee.
- Granted option to purchase 150,437 shares vesting over two years at market price on grant date.
- Board determined Robinson qualifies as independent under Nasdaq rules; no family relationships or arrangements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023047951/0000950170-23-047951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023047951/eldn-20230911.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-047951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer